The MIDORA trial: a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritis
Article in RMD Open (August 2023)
The most recent citing publications are shown below. View all 29 publications that cite this research output on Dimensions.
Article in RMD Open (August 2023)
Article in Cell Death Discovery (July 2023)
Article in Frontiers in Immunology (February 2023)